本研究建立了一种简单、可靠、高效的定量检测电压门控KCNQ/M钾通道开放剂QO58-lysin在大鼠血浆中浓度的方法。采用高效液相色谱与紫外检测器,使用反相C18色谱柱,以0.2 M的乙酸铵–乙腈(40:60,v/v)为流动相,尼群地平(nitrendipine)为内标物。QO58-lysin与尼群地平的色谱峰保留时间分别为3.8 min与5.4 min。QO58-lysin在0.1–120μg/mL浓度范围内具有良好线性(r2=0.9996),最低检测浓度为0.1μg/mL。根据FDA指南,检测方法的准确度、精密度、回收率与稳定性皆符合要求。该方法成功应用于测定SD大鼠单剂量尾静脉注射QO58-lysin(10 mg/kg)的药代动力学研究。化合物QO58-lysin在大鼠血浆的半衰期和消除半衰期分别为(0.25±0.16)h和(2.15±0.12)h。
A simple, reliable and efficient assay for quantitative analysis of a novel Kv7/KCNQ/M-channel opener QO58-lysin in rat plasma was developed using high-performance liquid chromatography(HPLC) with UV detection. Separation of compound QO58-lysin from plasma was achieved using a reverse-phase C18 column with a mobile phase of 0.2 M ammonium acetate in H2O–acetonitrile(40:60, v/v) with nitrendipine used as an internal standard(IS). The retention times of QO58-lysin and the IS in rat plasma were 3.8 and 5.4 min, respectively. Calibration curve was linear ranging from 0.1 to 120 μg/mL with correlation coefficient(r2) of 0.9996. The lower limit of quantification was 0.1 μg/mL. Accuracy, precision, recovery as well as stability were all within acceptable criteria according to Food and Drug Administration(FDA) guidelines. This validated assay was successfully applied to determine the pharmacokinetics of QO58-lysin administered intravenously(10 mg/kg) in SD rats. The distribution and elimination half-life of QO58-lysin in plasma was(0.25±0.16) h and(2.15±0.12) h, respectively.